Language selection

Government of Canada / Gouvernement du Canada

Search

Updated recommendations on human papillomavirus (HPV) vaccines : 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule.: HP40-157/2017E-PDF

"In February 2015, a nine-valent human papillomavirus vaccine (HPV9) (Gardasil®9, Merck Canada, Inc.) was authorized for use in Canada. The purpose of this statement is to summarize information on this vaccine and to provide evidence-based recommendations on its use in the context of recommendations for all HPV vaccines currently authorized for use in Canada. In addition, this statement will clarify minimum intervals between doses of HPV vaccines for two-dose and three-dose HPV immunization schedules"--Introduction, p. 7.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.833902&sl=0

Publication information
Department/Agency
  • Canada. National Advisory Committee on Immunization.
  • Public Health Agency of Canada.
TitleUpdated recommendations on human papillomavirus (HPV) vaccines : 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule.
Variant title
  • At head of title: Advisory committee statement (ACS) - National Advisory Committee on Immunization (NACI)
  • 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule
Publication typeMonograph
Language[English]
Other language editions[French]
Earlier editionUpdated recommendations on human papillomavirus (HPV) vaccines
FormatDigital text
Electronic document
Note(s)
  • Issued also in HTML format.
  • Issued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : vaccin nonavalent contre le VPH et précisions sur les intervalles minimums entre les doses dans le calendrier d'immunisation contre le VPH.
  • Includes bibliographical references.
Publishing information
  • [Ottawa] : Public Health Agency of Canada, 2017.
Description55 p.
ISBN978-0-660-08004-8
Catalogue number
  • HP40-157/2017E-PDF
Departmental catalogue numberPub.: 160384
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: